IFN-γ和IL-2联合检测在老年结核性胸膜炎与恶性胸腔积液鉴别诊断中的应用OA
Application of combined interferon-γ and interleukin-2 detection in the differential diagnosis of tuberculous pleural effusion and malignant pleural effusion in elderly patients
目的 探讨老年结核性胸膜炎(TPE)与恶性胸腔积液(MPE)患者的多项炎症指标联合结核分枝杆菌特异性γ干扰素(IFN-γ)和白细胞介素-2(IL-2)(双因子)的鉴别诊断价值.方法 选择 2023年1月至2024年12月就诊于兰州市肺科医院≥60周岁的140例胸腔积液患者进行回顾性分析,其中TPE组患者80例,MPE组患者60例.收集患者结核特异性细胞因子IFN-γ和IL-2联合检测结果;红细胞沉降率(ESR);血清中C-反应蛋白(CRP)、乳酸脱氢酶(LDH)、腺苷脱氨酶(ADA)以及胸水LDH、胸水ADA检测结果,比较各指标在TPE组和MPE组的诊断效能.结果 TPE组和MPE组间平均年龄差异无统计学意义(P>0.05),TPE组男性比例显著高于MPE组(P<0.05).两组指标中位数比较,TPE组患者结核特异性IFN-γ和IL-2以及ESR、血清ADA、胸水ADA显著高于MPE组患者(P<0.05),血清LDH显著低于MPE组患者(P<0.05),而血清CRP和胸水LDH差异无统计学意义(P>0.05).以IFN-γ≥7pg/mL和(或)IL-2≥20 pg/mL为诊断标准时,敏感度为82.5%、特异度为85.0%、准确度为83.6%;其中在恶性胸腔积液患者中IFN-γ和IL-2双阳特异度高为98.33%;IFN-γ、IL-2及双因子联合检测AUC值分别为0.820、0.807、0.823,双因子联合检测的AUC值最高,且显著高于ESR(Z=2.094,P=0.036)、血清LDH(Z=3.471,P=0.000)和血清ADA(Z=2.500,P=0.012)的AUC值,与胸水ADA检测的AUC值差异无统计学意义(Z=0.535,P=0.592).同时,双因子检测联合胸水中 ADA 的 AUC 值为 0.897(95%CI:0.834~0.942),显著高于双因子联合检测(Z=2.056,P=0.040)、胸水ADA(Z=3.082,P=0.002)的AUC值.结论 结核特异性细胞因子IFN-γ和IL-2联合检测在结核性胸膜炎与恶性胸腔积液鉴别中具有较好的效果,尤其IFN-γ和IL-2双阳时,特异度最高,并且联合胸水ADA检测在结核性胸膜炎中具有更好的诊断效果.
Objective To investigate the diagnostic value of multiple inflammatory markers combined with Myco-bacterium tuberculosis-specific interferon-γ(IFN-γ)and interleukin-2(IL-2)dual-factor detection in differen-tiating tuberculous pleural effusion(TPE)from malignant pleural effusion(MPE)in elderly patients.Methods A ret-rospective analysis was conducted on 140 patients aged ≥60 years with pleural effusion admitted to Lanzhou Pulmonary Hospital from January 2023 to December 2024.Among them,80 cases were diagnosed as TPE and 60 as MPE.Laboratory parameters including Mycobacterium tuberculosis-specific IFN-γ and IL-2,erythrocyte sedimentation rate(ESR),serum C-reactive protein(CRP),serum lactate dehydrogenase(LDH),serum adenosine deaminase(ADA),and pleu-ral fluid LDH and ADA were collected and compared between the two groups.Diagnostic performance of each indicator and their combinations was evaluated by receiver operating characteristic(ROC)curve analysis.Results There was no significant difference in mean age between the TPE and MPE groups(P>0.05),but the proportion of males was signifi-cantly higher in the TPE group(P<0.05).Compared with the MPE group,TPE patients showed significantly higher lev-els of IFN-γ,IL-2,ESR,serum ADA,and pleural ADA(P<0.05),while serum LDH was significantly lower(P<0.05).No significant differences were found in serum CRP or pleural LDH(P>0.05).Using IFN-γ≥7 pg/mL and/or IL-2 ≥20 pg/mL as diagnostic thresholds yielded a sensitivity of 82.5%,specificity of 85.0%,and overall accuracy of 83.6%.In MPE patients,dual IFN-γ and IL-2 positivity demonstrated the highest specificity(98.33%).The area under the curve(AUC)values for IFN-γ,IL-2,and combined dual-factor detection were 0.820,0.807,and 0.823,respectively.The dual-factor AUC was significantly higher than those of ESR(Z=2.094,P=0.036),serum LDH(Z=3.471,P=0.000),and serum ADA(Z=2.500,P=0.012),but not significantly different from pleural ADA(Z=0.535,P=0.592).Moreover,combining dual-factor detection with pleural ADA yielded an AUC of 0.897(95%CI:0.834-0.942),significantly higher than either test alone(Z=2.056,P=0.040;Z=3.082,P=0.002,respectively).Conclusion Combined detection of Mycobacterium tuberculosis-specific IFN-γ and IL-2 provides valuable diagnostic information for differentiating tuberculous pleural effusion from malignant pleural effusion in elderly pa-tients.Dual positivity(IFN-γ/IL-2)offers the highest specificity,and the addition of pleural ADA measurement fur-ther enhances diagnostic accuracy.
张鑫;邢惟俊;杨增伟;姚文;徐芳;同重湘
兰州市肺科医院(甘肃省传染病医院)检验科(甘肃兰州 730046)甘肃省第二人民医院外科(甘肃兰州 730046)兰州市肺科医院(甘肃省传染病医院)检验科(甘肃兰州 730046)兰州市肺科医院(甘肃省传染病医院)检验科(甘肃兰州 730046)兰州市肺科医院(甘肃省传染病医院)检验科(甘肃兰州 730046)兰州市肺科医院(甘肃省传染病医院)检验科(甘肃兰州 730046)
医药卫生
结核性胸膜炎恶性胸腔积液炎症指标双因子联合检测鉴别诊断
tuberculous pleural effusionmalignant pleural effusioninflammatory markersdual-factor detec-tiondifferential diagnosis
《广东医学》 2026 (1)
39-44,6
国家重点研发专项(2023YFC2307200-2023YFC2307201)兰州市科技发展指导性计划项目(2024-9-212)兰州市科技发展计划项目(2023-ZD-155)
评论